VIMTA LABS
|
VIMTA LABS Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 17.35 | 30.02 | 22.02 | 21.37 | 18.57 |
| CEPS(Rs) | 27.15 | 22.95 | 18.48 | 17.59 | 14.52 |
| DPS(Rs) | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Book NAV/Share(Rs) | 100.63 | 167.37 | 138.66 | 123.92 | 104.37 |
| Tax Rate(%) | 25.44 | 24.99 | 21.91 | 25.90 | 25.82 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 34.75 | 35.45 | 32.59 | 29.69 | 28.90 |
| EBIT Margin(%) | 25.81 | 26.43 | 22.39 | 21.10 | 20.60 |
| Pre Tax Margin(%) | 25.52 | 25.87 | 21.66 | 20.26 | 20.06 |
| PAT Margin (%) | 19.03 | 19.41 | 16.91 | 15.01 | 14.88 |
| Cash Profit Margin (%) | 29.78 | 29.67 | 28.40 | 24.70 | 23.27 |
| Performance Ratios | |||||
| ROA(%) | 15.25 | 15.76 | 13.14 | 14.33 | 14.25 |
| ROE(%) | 18.87 | 19.65 | 16.78 | 18.73 | 19.32 |
| ROCE(%) | 24.81 | 25.23 | 20.55 | 24.25 | 23.85 |
| Asset Turnover(x) | 0.80 | 0.81 | 0.78 | 0.95 | 0.96 |
| Sales/Fixed Asset(x) | 0.84 | 0.91 | 0.91 | 1.11 | 1.14 |
| Working Capital/Sales(x) | 2.56 | 2.79 | 2.79 | 2.97 | 3.57 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.19 | 1.10 | 1.09 | 0.90 | 0.87 |
| Receivable days | 94.97 | 102.52 | 105.54 | 90.82 | 99.27 |
| Inventory Days | 24.65 | 26.39 | 29.92 | 23.16 | 21.17 |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 21.95 | 16.66 | 10.10 | 7.35 | 8.48 |
| PCE(x) | 14.03 | 21.79 | 12.03 | 8.93 | 10.85 |
| Price/Book(x) | 3.78 | 5.98 | 3.21 | 2.54 | 3.02 |
| Yield(%) | 0.53 | 0.20 | 0.45 | 0.64 | 0.63 |
| EV/Net Sales(x) | 4.02 | 6.39 | 3.39 | 2.13 | 2.55 |
| EV/Core EBITDA(x) | 10.89 | 17.43 | 10.02 | 6.92 | 8.67 |
| EV/EBIT(x) | 15.59 | 24.19 | 15.15 | 10.10 | 12.39 |
| EV/CE(x) | 3.56 | 5.68 | 2.94 | 2.27 | 2.79 |
| M Cap / Sales | 4.18 | 6.46 | 3.42 | 2.21 | 2.52 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 18.40 | 19.19 | -8.42 | 14.18 | 32.02 |
| Core EBITDA Growth(%) | 19.27 | 29.09 | 0.76 | 19.44 | 51.82 |
| EBIT Growth(%) | 15.64 | 40.70 | -2.81 | 16.94 | 85.98 |
| PAT Growth(%) | 16.11 | 36.76 | 3.20 | 15.20 | 93.12 |
| EPS Growth(%) | -42.20 | 36.36 | 3.01 | 15.10 | 93.12 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.02 | 0.06 | 0.05 | 0.08 |
| Current Ratio(x) | 3.43 | 2.92 | 2.91 | 2.87 | 2.64 |
| Quick Ratio(x) | 2.97 | 2.53 | 2.46 | 2.47 | 2.27 |
| Interest Cover(x) | 90.08 | 47.84 | 30.75 | 25.14 | 38.00 |
| Total Debt/Mcap(x) | - | - | 0.02 | 0.02 | 0.03 |
Compare Financial Ratios of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,364.0 Cr | 12.8% | 4.7% | 12.7% | Stock Analytics | |
| PRIME FOCUS | ₹19,236.8 Cr | 7.7% | -19.4% | 123.6% | Stock Analytics | |
| SAGILITY | ₹18,257.2 Cr | -6.3% | -9.2% | 2.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,132.8 Cr | 1.9% | -4.3% | -33.1% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,778.2 Cr | 0.8% | 0.4% | -3.5% | Stock Analytics | |
| INDEGENE | ₹12,370.3 Cr | -1% | -3.3% | -13.6% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 12.8% |
4.7% |
12.7% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses